Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2021

View Archived Issues

AFYX Therapeutics presents preclinical data on anti-TNF antibody delivery through adhesive patch

Small-molecule OXS-7417 shows in vivo AML antitumoral effects

StemSynergy Therapeutics patents N-myc proto-oncogene protein inhibitors

Salk Institute, Sanford Burnham Prebys describe new ULK1 inhibitors

New PIKfyve inhibitors identified at AcuraStem

Discovery of novel antibiotic class of tethered macrocyclic peptides

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

HA-344 shows promise for treating cutaneous metastatic melanoma

PearlRiverBio patents mutant EGFR/HER2 inhibitors

STM-2457: a first-in-class METTL3 inhibitor with preclinical proof of concept in AML models

Flamingo and Ionis expand alliance to develop RNA-targeted therapies for oncology

GRC-39815 shows efficacy in models of smoke-induced COPD

Vitalgenics reports preclinical findings with excindogen in PDAC

Twist collaborates with Boehringer Ingelheim on antibody research programs

KG207-M, a novel bifunctional fusion protein as disease-modifying therapy for AD

Platinum(II)-NHC complex targeting vimentin inhibits tumor metastasis

fMLP receptor promotes inflammatory brain injury

At WCLC, early steps towards success against SCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...